Welcome!
Coastal Cancer Center provides patients with cancer and blood disorders the most current advances in treatment close to the support and convenience of home. Doctors and clinical staff understand that cancer care is about more than medical treatment – it is about care for the whole person. Patients are treated through a team approach in a relaxed, community-based environment of care, compassion and hope.
 Click here to learn more about our QOPI Certification |
 |
Latest Cancer News
Antidepressant Cymbalta May Reduce Pain from Chemotherapy-Induced Peripheral Neuropathy
(05-24-2013)
The antidepressant Cymbalta® (duloxetine) appears to reduce the numbness and tingling associated with taxane or platinum-based chemotherapy, according to the results of a study published in the Journal... Continue Reading
Breast-Conserving Therapy Comparable to Mastectomy for Women with Early-Stage Triple-Negative Breast Cancer (05-23-2013)
In a study of more than 600 women with early-stage triple-negative breast cancer treated at a single institution, treatment with breast-conserving therapy was as effective as total mastectomy. These results... Continue Reading
Intermittent Zelboraf Treatment in Patients with Melanoma May Prevent Resistance to the Drug (05-22-2013)
Tumors resistant to Zelboraf® (vemurafenib) in patients with melanoma showed reduced growth after treatment was stopped. What’s more—animal models have shown that drug resistance was prevented by... Continue Reading
The antidepressant Cymbalta® (duloxetine) appears to reduce the numbness and tingling associated with taxane or platinum-based chemotherapy, according to the results of a study published in the Journal... Continue Reading
Breast-Conserving Therapy Comparable to Mastectomy for Women with Early-Stage Triple-Negative Breast Cancer (05-23-2013)
In a study of more than 600 women with early-stage triple-negative breast cancer treated at a single institution, treatment with breast-conserving therapy was as effective as total mastectomy. These results... Continue Reading
Intermittent Zelboraf Treatment in Patients with Melanoma May Prevent Resistance to the Drug (05-22-2013)
Tumors resistant to Zelboraf® (vemurafenib) in patients with melanoma showed reduced growth after treatment was stopped. What’s more—animal models have shown that drug resistance was prevented by... Continue Reading
